Celcuity (CELC) Change in Interest Receivables (2018 - 2019)

Celcuity (CELC) posted Change in Interest Receivables of -$7963.0 for Q1 2019, down 133.3% on a QoQ basis from $23912.0 in Q1 2018, and down 133.3% year-over-year from $23912.0 in Q1 2018.

Celcuity (CELC) Change in Interest Receivables (2018 - 2019) Analysis & Trends

Celcuity's Change in Interest Receivables history runs 2 years deep, the most recent figure standing at -$7963.0 for Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Interest Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Celcuity 4.13 Bn 4.13 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2019 -7,963.00
Mar 31, 2018 23,912.00